BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Assay Designs, Inc. Names New CEO


4/25/2007 10:58:36 AM

ANN ARBOR, Mich., April 25 /PRNewswire/ -- Assay Designs, Inc. (ADI), a leading provider of immunoassay kits, antibodies, and reagents to the life sciences and translational research markets, has appointed Dan Calvo as President and Chief Executive Officer. Prior to joining ADI, Mr. Calvo was President and CEO of Cellomics, Inc. in Pittsburgh, PA, a leading provider of high content cellular screening platforms, which was acquired by Fisher Scientific International (now Thermo Fisher Scientific) in August 2005. Mr. Calvo has also served as Vice President of Worldwide Sales and Service for PerkinElmer Life and Analytical Sciences, and Senior Vice President of NEN Life Sciences, which was acquired by PerkinElmer in 2000.

"I am delighted about the opportunity to lead Assay Designs as it enters an expansion phase," commented Mr. Calvo. "ADI has high quality products, strong development capabilities and well-established brands in the life sciences research community. By leveraging these strengths and accelerating the addition of new products via internal development and external partnerships, we will strengthen our position as a preeminent, global supplier of innovative reagents and assays."

David Parker, Chairman of Assay Designs and a General Partner at Ampersand Ventures stated, "Dan has a proven track record in the research products sector. His experience leading the transformation of Cellomics from an entrepreneurial, technology venture into a high growth, professionally-run business and building meaningful stakeholder value in the process is particularly relevant to ADI. His energy, leadership, strategic bandwidth and operational strength will serve to evolve ADI into a top-tier life sciences tools company."

About Assay Designs, Inc.

Based in Ann Arbor, MI, Assay Designs develops, manufactures and markets immunoassay (ELISA) kits, luminescent reagents, antibodies, proteins, DNA products, and extracts that are used for life sciences research. The Company markets these products under the "Assay Designs" and "Stressgen" brand names. Researchers use the Company's products to detect and quantify molecules that are important in inflammation, cell signaling and oxidative stress.

Assay Designs, Incorporated

CONTACT: Emily Riesterer of Assay Designs, Inc., +1-800-833-8651,info@assaydesigns.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES